“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...

Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory ...

We recently published a list of 10 Firms End 2024 Stronger With Impressive Gains. In this article, we are going to take a ...

Moderna advances combo vaccine for flu and COVID-19 with trials starting in March Pharmaceutical companies gear up to tackle ...

With a state grand jury report released Wednesday, Florida Gov. Ron DeSantis doubled down on the message he delivered often ...

The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Discover CDC findings on COVID-19 variants and vaccine protection, revealing key insights into emerging strains and public ...

Vaccine stocks and EV maker Lucid Technologies (LCID) are among today’s biggest winners today. Vaccine makers, including Moderna (MRNA), Novavax (NVAX), and BioNTech (BNTX), are rallying after the ...

Earlier last year, the vaccine maker announced ... which covers a multi-year extension with Moderna (MRNA) to utilize Personalis’ ImmunoID NeXT Platform and technology for V940/mRNA-4157 ...